Back to Search
JAYNE LEONARD, MD
MD
Family Medicine Physician
NPI: 1457391401IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
34513(NC)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 1990
Research & Publications (20)
Reaching to multiple targets when standing: the spatial organization of feedforward postural adjustments.
PMID 19211658·J Neurophysiol·2009
8-other
Predicting Toll-like receptor structures and characterizing ligand binding.
PMID 19378017·Methods Mol Biol·2009
7-preclinical
Stability of zinc oxide nanofluids prepared with aggregated nanocrystalline powders.
PMID 19205207·J Nanosci Nanotechnol·2008
8-other
HIV evades RNA interference directed at TAR by an indirect compensatory mechanism.
PMID 18996348·Cell Host Microbe·2008
8-other
Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphoma.
PMID 18853418·Cancer·2008
3-trial
Targeted treatment and new agents in diffuse large B-cell lymphoma.
PMID 18760704·Semin Hematol·2008
6-review
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.
PMID 18349031·Ann Oncol·2008
8-other
The TLR3 signaling complex forms by cooperative receptor dimerization.
PMID 18172197·Proc Natl Acad Sci U S A·2008
8-other
Identification of a candidate gene for the wheat endopeptidase Ep-D1 locus and two other STS markers linked to the eyespot resistance gene Pch1.
PMID 17952400·Theor Appl Genet·2008
4-observational
Enhanced preparation of adeno-associated viral vectors by using high hydrostatic pressure to selectively inactivate helper adenovirus.
PMID 17252611·Biotechnol Bioeng·2007
8-other
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma.
PMID 17470451·Ann Oncol·2007
3-trial
Analysis of dishevelled localization and function in the early sea urchin embryo.
PMID 17433285·Dev Biol·2007
7-preclinical
Proteasome inhibition with bortezomib: a new therapeutic strategy for non-Hodgkin's lymphoma.
PMID 16557600·Int J Cancer·2006
6-review
Antiviral RNAi therapy: emerging approaches for hitting a moving target.
PMID 16177819·Gene Ther·2006
6-review
Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape.
PMID 15650190·J Virol·2005
8-other
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.
PMID 16110029·J Clin Oncol·2005
3-trial
New developments in immunotherapy for non-Hodgkin's lymphoma.
PMID 16091197·Curr Oncol Rep·2005
6-review
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.
PMID 15328168·Clin Cancer Res·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 HOSPITAL AVE STE 7
JEFFERSON, NC 28640 - Phone
- (336) 846-7238
Quick Facts
- NPI
- 1457391401
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile